CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoGHISLANDI, SIMONE
Pubblicazioni
Risultati 1 - 20 di 34 (tempo di esecuzione: 0.002 secondi).
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore | |
|---|---|---|---|---|---|
| 1 | Adaptation to poverty in long-run panel data | 2016 | Clark, Andrew; D'Ambrosio, Conchita; Ghislandi, Simone | THE REVIEW OF ECONOMICS AND STATISTICS | |
| 2 | Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data | 2013 | Ghislandi, Simone; Torbica, Aleksandra; Boriani, G. | BMC HEALTH SERVICES RESEARCH | |
| 3 | Competition and the Reference Pricing Scheme for pharmaceuticals | 2011 | Ghislandi, Simone | JOURNAL OF HEALTH ECONOMICS | |
| 4 | Competition and the Reference Pricing Scheme for pharmaceuticals | 2009 | Ghislandi, Simone | ||
| 5 | Diffusion of medical technology:The role of financing | 2011 | Cappellaro, Giulia; Ghislandi, Simone; ANESSI PESSINA, Eugenio | HEALTH POLICY | |
| 6 | The economic crisis and acute myocardial infarction: new evidence using hospital-level data | 2015 | Torbica, Aleksandra; Maggioni, ALDO PIETRO; Ghislandi, Simone | PLOS ONE | |
| 7 | Effects of Reference Pricing in Pharmaceutical Markets: A Review | 2011 | M., Galizzi; Ghislandi, Simone; M., Miraldo | PHARMACOECONOMICS | |
| 8 | Effects of the economic crisis on smoking prevalence and number of smokers in the USA | 2015 | Gallus, Silvano; Ghislandi, Simone; Muttarak, Raya | TOBACCO CONTROL | |
| 9 | Fair choices in universal health coverage in Thailand | 2016 | Ghislandi, Simone; Muttarak, Raya | THE LANCET | |
| 10 | Family income and material deprivation: do they matter for sleep quality and quantity in early life? evidence from a longitudinal study | 2017 | Barazzetta, Marta; Ghislandi, Simone | SLEEP | |
| 11 | Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy | 2020 | Veronesi, Giulia; Navone, Niccolò; Novellis, Pierluigi; Dieci, Elisa; Toschi, Luca; Velutti, Laura; Solinas, Michela; Vanni, Elena; Alloisio, Marco; GHISLANDI, SIMONE | LUNG CANCER | |
| 12 | How do italian pharmacoeconomists evaluate indirect costs? | 2000 | Garattini, L; Tediosi, Fabrizio; Ghislandi, Simone; Orzella, L; Rossi, C. | VALUE IN HEALTH | Blackwell Science Incorporated:350 Main Street, Sixth Floor:Malden, MA 02148:(888)661-5800, (781)388-8250, EMAIL: csjournals@blacksci.com, INTERNET: http://www.blackwell-science.com, Fax: (781)388-8232 |
| 13 | How do italian pharmacoeconomists evaluate indirect costs? | 2000 | L., Garattini; Tediosi, Fabrizio; Ghislandi, Simone; L., Orzella; C., Rossi | VALUE IN HEALTH | |
| 14 | The impact of generic reference pricing in Italy, a decade on | 2013 | Ghislandi, Simone; Armeni, Patrizio; Jommi, Claudio | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS | |
| 15 | The impact of generic reference pricing in Italy, a decade on | 2013 | Ghislandi, Simone; Armeni, Patrizio; Jommi, Claudio | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS | |
| 16 | The impact of Universal Health Coverage on health care consumption and risky behaviours: evidence from Thailand | 2014 | Ghislandi, Simone; Wanwiphang, Manachotphong; Perego, VIVIANA MARIA EUGENIA | HEALTH ECONOMICS, POLICY AND LAW | |
| 17 | L'inclusione dei costi indiretti nelle valutazioni economiche: la situazione italiana. | 2000 | Tediosi, Fabrizio; Ghislandi, Simone; Garattini, Livio | MECOSAN | SIPIS, Roma |
| 18 | Inequalities in the benefits of national health insurance on financial protection from out-of-pocket payments and access to health services: cross-sectional evidence from Ghana | 2019 | Fiestas Navarrete, Lucia; Ghislandi, Simone; Stuckler, David; Tediosi, Fabrizio | HEALTH POLICY AND PLANNING | |
| 19 | Is EQ-5D a valid measure of HRQoL in patients with movement disorders? | 2002 | Ghislandi, Simone; Apolone, G; Garattini, L; Ghislandi, I. | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS | Springer Berlin Heidelberg |
| 20 | Italian Pharmaceutical Policy: Towards a Structural Change? | 2005 | Ghislandi, Simone; Krulikova, I; Garattini, L. | HEALTH POLICY |
Dettaglio
GHISLANDI, SIMONE
Dipartimento di Scienze sociali e politiche
Copyright © 2020